The Serum Institute of India (SII) had on Monday said it will apply for license from the Indian regulator to start clinical trials of the shot in a week's time
from Livemint - News https://ift.tt/2WLN8St
https://ift.tt/eA8V8J
from Livemint - News https://ift.tt/2WLN8St
https://ift.tt/eA8V8J
Post a Comment